- Report
- October 2024
- 195 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- September 2024
- 100 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- April 2025
- 141 Pages
Global
From €2739EUR$2,999USD£2,342GBP
- Report
- April 2025
- 254 Pages
Global
From €5343EUR$5,850USD£4,569GBP
- Report
- February 2025
- 150 Pages
Global
From €3608EUR$3,950USD£3,085GBP
- Report
- October 2024
- 191 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- October 2024
- 185 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- April 2025
- 287 Pages
Global
From €5343EUR$5,850USD£4,569GBP
- Report
- January 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- July 2024
- 119 Pages
Global
From €4110EUR$4,500USD£3,515GBP
- Report
- August 2024
- 200 Pages
Global
From €4520EUR$4,949USD£3,865GBP
- Report
- February 2023
- 258 Pages
Global
From €4521EUR$4,950USD£3,866GBP
- Report
- August 2023
- 313 Pages
Global
From €3836EUR$4,200USD£3,280GBP
- Report
- October 2023
- 190 Pages
Global
From €4110EUR$4,500USD£3,515GBP
- Report
- February 2024
- 120 Pages
Global
From €4338EUR$4,750USD£3,710GBP
- Report
- September 2023
- 331 Pages
Global
From €4064EUR$4,450USD£3,476GBP
- Report
- March 2024
- 115 Pages
Africa, Middle East
From €3151EUR$3,450USD£2,694GBP
- Report
- March 2024
- 101 Pages
From €3151EUR$3,450USD£2,694GBP
- Report
- March 2024
- 138 Pages
Asia Pacific
From €3151EUR$3,450USD£2,694GBP
- Report
- March 2024
- 162 Pages
Europe
From €3151EUR$3,450USD£2,694GBP

The Infection Surveillance Solutions market is a subset of the Infectious Disease Testing market, focusing on the development of solutions to monitor and track the spread of infectious diseases. These solutions are designed to provide healthcare professionals with the data and insights they need to identify and respond to potential outbreaks. Solutions may include software, hardware, and services that enable the collection, analysis, and sharing of data related to infectious diseases.
The Infection Surveillance Solutions market is driven by the need to improve public health outcomes and reduce the economic impact of infectious diseases. Governments, healthcare providers, and other stakeholders are increasingly investing in solutions to better understand and respond to the spread of infectious diseases.
Companies in the Infection Surveillance Solutions market include IBM, Epic Systems, Cerner Corporation, Allscripts, and Athenahealth. Show Less Read more